PARP1 and cancer: Overall, our data suggest that TLK expression is functionally linked to PARPi sensitivity in BRCA1-mutant cells and highlight the role of TLK proteins in modulating the anticancer effects of PARP inhibition, particularly in challenging cancer types such as TNBC and HGSOC.